• 3:55

  Clinical development of novel pharmacological treatments for Alzheimer’s disease

  Jakub Hort

  At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub…
• 1:57

  New approaches for developing disease modifying therapies in Alzheimer’s disease

  Jakub Hort

  At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub…
• 1:09

  Combination therapy for Alzheimer’s disease

  Serge Gauthier

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Serge Gauthier,…
• 1:51

  Potential new symptomatic drugs for Alzheimer’s disease

  Serge Gauthier

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Serge Gauthier,…
• 3:14

  Evaluating the effect of diabetes drug liraglutide for Alzheimer’s disease

  Doug Brown

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown,…
• 1:27

  An update on disease-modifying treatments for dementia

  Doug Brown

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown,…
• 2:43

  Ginkgo biloba extract EGb 761® for cognitive impairment: clinical data

  Amos Korczyn

  At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Amos…
• 3:08

  LipiDiDiet: Evidence-based multi-nutrient intervention for prodromal Alzheimer’s disease

  Tobias Hartmann

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Tobias Hartmann,…